---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-26-038356"
form_type: "8-K"
ticker: "FOXO"
cik: "0001812360"
company_name: "FOXO TECHNOLOGIES INC."
filed_at: "2026-08-14T20:10:43+00:00"
generated_at: "2026-08-14T20:17:41.680826+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# FOXO majority stockholder approves reverse stock split for potential Nasdaq/NYSE American uplisting

## Summary
- On Aug 13, 2026, Rennova Health (controlled by CEO) approved reverse split amendment via written consent.
- Ratio range 1:50 to 1:1,000; exact ratio set by board solely to facilitate uplisting to Nasdaq or NYSE American.
- Record date Aug 13, 2026; majority stockholder holds ~99.12% of voting rights.
- Reverse split effective no earlier than 20 days after mailing definitive Schedule 14C; FINRA notice required.
- Preliminary Schedule 14C filed Aug 14, 2026; board authorized split only for uplisting application.

## SEC filing metadata
- accession: 0001493152-26-038356
- form_type: 8-K
- ticker: FOXO
- cik: 0001812360
- company_name: FOXO TECHNOLOGIES INC.
- filed_at: 2026-08-14T20:10:43+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1812360/000149315226038356/0001493152-26-038356-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1812360/000149315226038356/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-26-038356
- JSON: https://secwatch.observer/filing/0001493152-26-038356.json
- Plain text: https://secwatch.observer/filing/0001493152-26-038356.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.